Showing results (271-280 of 358) with videos related to

Sort By:
Pageof 36
Frontiers in Psychiatry|August 23, 2021
Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse ModelRoberto Farina Almeida, Yasmine Nonose, Marcelo Ganzella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2025
Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer's diseaseIlaria Pola, Nicholas J Ashton, Marco Antônio De Bastiani, et al.
Molecular Neurobiology|March 9, 2017
Cortical Bilateral Adaptations in Rats Submitted to Focal Cerebral Ischemia: Emphasis on Glial MetabolismYasmine Nonose, Pedro E Gewehr, Roberto F Almeida, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2022
Clozapine induces astrocyte-dependent FDG-PET hypometabolismAndréia Rocha, Bruna Bellaver, Débora G Souza, et al.
Molecular Metabolism|November 17, 2023
Short-term consumption of highly processed diets varying in macronutrient content impair the sense of smell and brain metabolism in miceMelanie Makhlouf, Débora G Souza, Smija Kurian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging FrameworkArthur C Macedo, Cécile Tissot, Joseph Therriault, et al.
Neuroepidemiology|August 28, 2025
Polypill and RiskOMeter to Prevent StrOke and CogniTive ImpairmEnt in Primary Health Care (PROMOTE) Randomized Clinical Trial: Rationale and DesignMichael Brainin, Craig S Anderson, Philip M Bath, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's diseaseWagner S Brum, Marco Antônio de Bastiani, Andrei Bieger, et al.
The Journal of Prevention of Alzheimer'S Disease|February 20, 2024
Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's DiseaseA C Macedo, D F P A Durço, C Tissot, et al.
Nature Aging|August 31, 2023
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain casesWagner S Brum, Nicholas C Cullen, Shorena Janelidze, et al.
Pageof 36